UHLMANN PRICE SECURITIES’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$383K Sell
17,406
-9,084
-34% -$179K 0.01% 178
2026
Q1
$471K Buy
26,490
+779
+3% +$14.7K 0.03% 134
2025
Q4
$487K Buy
25,711
+781
+3% +$14.8K 0.29% 90
2025
Q3
$460K Buy
24,930
+1,658
+7% +$27.1K 0.28% 90
2025
Q2
$360K Sell
23,272
-1,461
-6% -$22.6K 0.26% 98
2025
Q1
$402K Buy
24,733
+1,015
+4% +$17.4K 0.3% 87
2024
Q4
$381K Sell
23,718
-3,241
-12% -$57.5K 0.29% 90
2024
Q3
$502K Buy
+26,959
New +$502K 0.4% 66

Other funds holding HQH

UHLMANN PRICE SECURITIES's HQH Position: Q2 2026 in Review

UHLMANN PRICE SECURITIES reduced its abrdn Healthcare Investors (HQH) stake by 34% in Q2 2026, selling an estimated $179K and leaving 17,406 shares worth $383K. The position accounts for 0.01% of the portfolio, ranked #178.

UHLMANN PRICE SECURITIES first reported a position in HQH in Q3 2024 and has held it in 8 quarters since. The position peaked at $502K in Q3 2024. 126 funds tracked by Wall St. Rank hold HQH as of Q2 2026.

  • UHLMANN PRICE SECURITIES held 17,406 shares of abrdn Healthcare Investors worth $383K as of Q2 2026.
  • UHLMANN PRICE SECURITIES sold 9,084 abrdn Healthcare Investors shares in Q2 2026, an estimated $179K.
  • abrdn Healthcare Investors made up 0.01% of UHLMANN PRICE SECURITIES's portfolio in Q2 2026, its #178 holding.
  • UHLMANN PRICE SECURITIES first reported a position in abrdn Healthcare Investors in Q3 2024 and has held it in 8 quarters since.
  • UHLMANN PRICE SECURITIES's abrdn Healthcare Investors position peaked at $502K in Q3 2024.
  • 126 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q2 2026.

Based on UHLMANN PRICE SECURITIES's 13F filing for Q2 2026, filed 24 Jul 2026.